Skip to main content
Cellular Immunotherapy Center Featured Clinical Trials
- Malignant Glioma (NCT02208362): Genetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant Glioma
- Acute Myeloid Leukemia/ Blastic Plasmacytoid Dendritic Cell Neoplasm (NCT02159495): Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm
- Acute Lymphoblastic Leukemia (NCT02146924): Cellular Immunotherapy in Treating Patients With High-Risk Acute Lymphoblastic Leukemia